Apogee Therapeutics: 'Strong Buy' As Zumilokibart Progresses To Next Q2 Milestone

Corroborated by 2 sources from 2 publishers

globalcrime2h ago

TL;DR

Reports differ across sources; according to seekingalpha.com, the last time I spoke about Apogee Therapeutics, Inc.

Investing.com News

https://www.investing.com/news/analyst-ratings/apogee-therapeutics-stock-price-target-raised-to-160-by-guggenheim-on-trial-data-93CH-4577240

Seeking Alpha Market News

https://seekingalpha.com/article/4885324-apogee-therapeutics-strong-buy-as-zumilokibart-progresses-to-next-q2-milestone?source=feed_all_articles